🧪 IN-ARMOR reaches a new milestone in nanocarrier development!
As part of WP3, led by @cinbio_uvigo , the project has successfully completed the optimisation and comprehensive characterisation of its mesoporous silica nanoparticle (MSNP)-based nanocarriers.
#EUFunded #HaDEA #AMR
🚀 This achievement strengthens the integration of nanotechnology, drug development and biological validation within the IN-ARMOR pipeline, supporting the progression of selected candidates towards preclinical evaluation.
#HostDirectedTherapy #Nanomedicine #DrugDelivery
👉 Discover more about our latest progress on the project website: inarmor-project.eu/
🧬 Why is this a major step?
By reinforcing the host’s innate immune system rather than directly targeting bacteria, we aim to tackle antimicrobial resistance (#AMR) without contributing to drug resistance.
Discover more🌐 inarmor-project.eu/
#EUfunded #HaDEA #DrugDevelopment
New milestone achieved!
The consortium has completed the advanced characterisation of its selected lead compounds for host-directed therapies (HDTs) against antimicrobial resistance.
🔗 inarmor-project.eu/
#EUFunded #HaDEA #INARMOR #HorizonEurope #HostDirectedTherapy
🧪 Led by #LEITAT, with the key collaboration of #UniversityofIceland and WP2 partners, the team assessed key ADME-related properties, Caco-2 permeability and potential mechanisms of action.
🚀 Another step towards preclinical validation and innovative approaches to tackle #AMR.
👏 Thank you to everyone who made these two days so productive.
🛡️🔬 Together, we continue working towards innovative approaches to tackle antimicrobial resistance (AMR).
#HaDEA #HorizonEurope #AMR #AntimicrobialResistance #HealthResearch
🌐 inarmor-project.eu
🔬 Plenary session: Updates spanning molecule synthesis and innate immunity to nanomedicine and regulatory activities across WP1–WP5.
💡 Technical workshops: Focused discussions on the experimental strategy and the selection of lead compounds for further development.
🚀 Tomorrow: Workshops on exploitation, dissemination & communication, IPR property (WP6–WP7), project management (WP8), and a technical visit to #HospitalUniversitarioRamonyCajal. 🧪🏥
🌐 inarmor-project.eu
#AMR #Nanomedicine #DrugDiscovery #HealthResearch
🚨 IN-ARMOR partners meet in Madrid! 🇪🇺
On 16–17 September, we hold our 4th Consortium Meeting & 14th Management Board Meeting, hosted by @SaludMadrid.
🤝 2 days to review progress, strengthen collaboration and plan the next steps in the fight against #AMR.
#EUFunded #HaDEA
🧬 IN-ARMOR is developing innovative approaches to strengthen the immune response against antimicrobial-resistant infections.
🌐 inarmor-project.eu
#HorizonEurope #AntimicrobialResistance #AMR #EUResearch
Grateful for the experiences! Huge thanks to @uniovi_info for giving us the opportunity to share our work. Thanks for having us! 🚀✨
Learn more about TUAI here: cordis.europa.eu/project/id/…
#ExplainableAI








